RSV: The Next Frontier in Respiratory Disease Management

RSV: The Next Frontier in Respiratory Disease Management

John Papastergiou and Ajit Johal wrap up their three-part series on respiratory diseases with a deep dive into respiratory syncytial virus (RSV). This episode explores the historical context of RSV, its impact on infants and older adults, and the emerging importance of vaccination. John and Ajit share insights into the latest testing technologies and the critical role pharmacists will play in managing and preventing RSV. Discover why RSV is becoming a significant focus in healthcare and how pharmacists can prepare for the next wave of respiratory disease management.

We are grateful to Pfizer Canada for their financial support of this educational program to help enhance the knowledge and education of pharmacists.

Back

Leave a comment

Please note, comments need to be approved before they are published.